Maintenance immunotherapy in advanced urothelial cancer
Advanced urothelial carcinoma usually responds to platinum-based chemotherapy (CT), although overall survival (OS) and progression-free survival are typically short. Immunotherapy is a promising treatment strategy, but the first-line benefits in platinum-eligible patients are limited, and its combin...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Permanyer
2022-07-01
|
| Edice: | Gaceta Mexicana de Oncología |
| Témata: | |
| On-line přístup: | https://www.gamo-smeo.com/frame_esp.php?id=323 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|